In particular, different studies have shown that GH/IGF-1 ratio in cerebrospinal fluid (CSF) and plasma are significantly lower in ALS patients in comparison with their control group [11-14]: these investigations demonstrate that ALS patients have a high prevalence of GH deficiency and at the same time increased levels of IGF-1. Here, GH1 is linked to amyotrophic lateral sclerosis.